Study of antibodies after operating-room allergic reactions
Part of Immune system & allergy clinical trials.
This study looks at different kinds of allergy-related antibodies in people who had an allergic reaction during surgery. The goal is to better understand what immune signals are involved so future allergy prevention and care can improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 70
- You had an allergic reaction during surgery in the past 10 years
- You already had an allergy and anesthesia consultation at the study center
- You are able to sign written consent (and are not in a legal protection situation like guardianship)
- You are not pregnant or breastfeeding, and you have social security
- You are not on immunosuppressing medicines or chemotherapy, and you have no acute heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests better ways to diagnose allergies to common cephalosporin antibiotics, like Keflex and Rocephin. By participating, you may learn if you are truly allergic to these medicines and if they are safe for you to take in the future.
This study looks at what causes severe allergic reactions during surgery. It helps doctors find out which medicine or substance triggered the reaction, so they can avoid it in the future.
This study collects information about people who had an allergic-type reaction around surgery or anesthesia. It aims to understand how often these reactions happen and to improve future care. You may be able to join if your reaction fits the time window and you agree to use your records.
This study looks closely at immune cells in children while they are having surgery under general anesthesia using a specific muscle-relaxing medicine (rocuronium). It may help researchers understand how immune systems respond around the time of surgery and anesthesia.
This study looks at IgE, a protein involved in allergic reactions, to better understand its role in different immune-related diseases. It aims to find out how different forms of IgE relate to health and disease, which may help improve diagnosis or treatment.
This trial follows people who have had anaphylaxis (a severe, life-threatening allergic reaction) within the last year. The goal is to better understand what happens over time so doctors can improve care.
Hear when a new Hypersensitivity, Immediate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.